Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Enteric fever

Infectious diseases, microbiology and sexual health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Complicated enteric fever

Shock, confusion, gastrointestinal bleeding, peritonism, severe dehydration or organ dysfunction may indicate sepsis, intestinal haemorrhage or ileal perforation.

Action: Use ABCDE, obtain blood cultures immediately without delaying treatment, start locally approved intravenous therapy with infection or microbiology input, and involve critical care and surgery early when perforation or uncontrolled bleeding is possible.

Synopsis

Recognise typhoid and paratyphoid after travel or food exposure, secure cultures before treatment when safe, manage severity and resistance intelligently, and complete exclusion, clearance and notification duties.

  • Enteric fever is systemic infection caused by Salmonella enterica serovars Typhi or Paratyphi, usually acquired through food or water contaminated by human faeces.
  • Think of sustained fever with headache, malaise and abdominal symptoms after travel to South Asia or another endemic region; diarrhoea, constipation or no bowel disturbance are all possible.
  • Blood culture is the first-line diagnostic test and should be obtained before antimicrobials whenever this does not delay treatment of a severely unwell patient.
  • Send stool culture as an additional investigation, but a negative stool result does not exclude acute disease; bone-marrow culture is more sensitive but is reserved for specialist diagnostic difficulty.
  • For uncomplicated disease without an extensively drug-resistant exposure, oral azithromycin 500 mg once daily for seven days is a current UK specialist-supported empirical option.
  • Complicated infection ordinarily requires intravenous ceftriaxone 2 g once daily; suspected complicated extensively drug-resistant disease may require meropenem plus azithromycin pending susceptibility.
  • Do not choose ciprofloxacin empirically because fluoroquinolone non-susceptibility is common; use it only when the isolate is fully susceptible and the specialist plan supports it.
  • Typhoid and paratyphoid are notifiable diseases in England. Notify on clinical suspicion and cooperate with the health protection team on exclusion, contact assessment and clearance cultures.

Key red flags

Hypotension, altered consciousness, rising lactate, oliguria or respiratory compromise indicates severe infection and requires immediate sepsis care.

Sudden worsening abdominal pain, guarding, rigidity, free air or unexplained deterioration suggests terminal ileal perforation and needs urgent surgical assessment.

Melaena, haematochezia, haematemesis, falling haemoglobin or circulatory instability can represent enteric-fever intestinal haemorrhage.

Travel from Pakistan, Iraq or another setting with extensively drug-resistant strains changes empirical therapy and demands immediate specialist microbiology advice.

Fever after tropical travel still requires urgent malaria films; identifying enteric fever does not safely exclude malaria or another concurrent infection.

Pregnancy, infancy, advanced age, immunosuppression and inability to take oral treatment lower the threshold for admission and intravenous therapy.

Progressive febrile illness

Fever usually rises over several days with headache, marked malaise, anorexia, dry cough or myalgia; the patient may look disproportionately unwell despite few focal signs.

Neurological disease

Confusion, delirium, reduced consciousness, seizure or focal neurology may accompany severe disease and should prompt glucose measurement, sepsis care and assessment for meningitis or cerebral malaria.

Investigation priorities

01
First-line blood culturesFirst stepFirst line

Confirm bacteraemia, identify Typhi or Paratyphi and generate the susceptibility profile that controls definitive therapy.

Management branches

SAMPLE FIRSTInvestigate suspected enteric fever

Sustained fever or compatible systemic illness follows residence in or travel to an endemic setting.

  1. Perform ABCDE, establish dates and exact locations, review antibiotics and vaccination, and assess for bleeding, peritonism, encephalopathy and shock.
  2. Take blood-culture sets before antimicrobials if this can be done immediately; add stool culture, severity bloods and urgent malaria testing without allowing sampling to delay resuscitation.
  3. Notify suspected typhoid or paratyphoid according to national arrangements and contact the health protection team early for risk-group, household and occupational advice.
  4. Ask microbiology or infection specialists to select empirical treatment from severity, likely geography and current resistance data, then narrow when organism and susceptibility are known.
UNCOMPLICATEDTreat stable oral disease

The patient has no shock, organ dysfunction, gastrointestinal complication or absorption problem and reliable follow-up is possible.

  1. For disease without an extensively drug-resistant exposure, use oral azithromycin 500 mg once daily for seven days as a supported empirical regimen, checking interactions and pregnancy.
  2. Review within 48 to 72 hours because fever may resolve slowly; confirm adherence, culture result and susceptibility rather than changing treatment for fever alone in a stable improving patient.

Key medicines

AzithromycinGive 500 mg orally once daily for seven days for uncomplicated susceptible or presumed non-extensively-drug-resistant enteric fever, unless specialist advice selects a different course.Review QT prolongation, interacting medicines, liver disease and pregnancy; vomiting or severe disease makes oral monotherapy unreliable, and susceptibility or clinical failure must prompt specialist reassessment.
CeftriaxoneGive 2 g intravenously once daily for complicated infection without a strong extensively-drug-resistant exposure, then step down only to a confirmed active oral agent when clinically appropriate.Check immediate beta-lactam allergy, biliary disease and local resistance; extended-spectrum beta-lactamase-producing Typhi may be resistant, so review every isolate result promptly.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Public health operational guidelines for typhoid and paratyphoid (enteric fever)
  • British Infection Association guidelines for the diagnosis and management of enteric fever in England
  • Typhoid and paratyphoid: public health guidance and questionnaires
  • Notifiable diseases and how to report them

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Intestinal complication

New bleeding, abrupt severe pain, involuntary guarding or septic deterioration after a longer febrile course suggests ileal ulcer haemorrhage or perforation.

  • If a culture-confirmed isolate is fully ciprofloxacin susceptible, a specialist may use ciprofloxacin 500 mg orally twice daily to complete seven days; do not infer susceptibility from a nalidixic-acid or geography shortcut.
  • Escalate to admission and intravenous treatment for vomiting, clinical deterioration, new focal abdominal signs or inability to guarantee completion and public-health follow-up.